Ribupatide
A Study to Evaluate the Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
Fujian Shengdi Pharmaceutical Co · Phase 2 · Completed · Enrollment 249
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.